US Stock MarketDetailed Quotes

Zentalis Pharmaceuticals (ZNTL)

Watchlist
  • 3.980
  • +0.090+2.31%
Close Apr 24 15:59 ET
  • 4.000
  • +0.020+0.50%
Post 20:01 ET
282.31MMarket Cap-2.08P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zentalis Pharmaceuticals (ZNTL) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
67.43M
26.87M
0
0
40.56M
Operating revenue
--0
--0
--0
--0
--0
--67.43M
--26.87M
--0
--0
--40.56M
Cost of revenue
Gross profit
Operating expense
-43.11%145.01M
-48.76%37.39M
-34.41%33.73M
-44.65%36.06M
-42.09%37.83M
0.37%254.88M
7.44%72.98M
-17.99%51.43M
11.65%65.15M
0.57%65.33M
Selling and administrative expenses
-56.70%37.72M
-80.24%7.91M
-26.18%10.78M
-49.60%8.45M
-32.78%10.58M
35.37%87.12M
144.45%40.01M
-8.43%14.61M
7.01%16.76M
-3.84%15.74M
-General and administrative expense
-56.70%37.72M
-80.24%7.91M
-26.18%10.78M
-49.60%8.45M
-32.78%10.58M
35.37%87.12M
144.45%40.01M
-8.43%14.61M
7.01%16.76M
-3.84%15.74M
Research and development costs
-36.05%107.3M
-10.57%29.49M
-37.68%22.95M
-42.94%27.61M
-45.05%27.25M
-11.51%167.77M
-36.05%32.97M
-21.26%36.82M
13.36%48.39M
2.06%49.59M
Operating profit
22.64%-145.01M
18.91%-37.39M
34.41%-33.73M
44.65%-36.06M
-52.74%-37.83M
26.18%-187.46M
32.11%-46.11M
17.99%-51.43M
-11.65%-65.15M
61.87%-24.77M
Net non-operating interest income expense
Other net income (expense)
-61.44%8.39M
267.46%2.62M
-37.38%7.04M
140.17%9.18M
-129.91%-10.45M
194.85%21.77M
-122.84%-1.56M
56.01%11.25M
44.40%-22.86M
750.52%34.95M
Gain on sale of security
-36.52%16.19M
20.58%2.62M
-37.38%7.04M
140.17%9.18M
-107.60%-2.66M
12.76%25.5M
-68.28%2.17M
56.01%11.25M
-613.66%-22.86M
750.52%34.95M
Special income (charges)
-108.67%-7.8M
--0
--0
--0
---7.8M
91.80%-3.74M
---3.74M
--0
--0
--0
-Less：Restructuring and merger&acquisition
--7.8M
--0
--0
--0
--7.8M
--0
--0
--0
--0
--0
-Less:Impairment of capital assets
--0
----
----
----
----
--3.74M
----
----
----
----
Income before tax
17.55%-136.62M
27.06%-34.77M
33.58%-26.69M
69.47%-26.87M
-574.11%-48.28M
40.16%-165.69M
21.94%-47.68M
27.61%-40.19M
11.52%-88.01M
116.74%10.18M
Income tax
149.72%442K
315.61%442K
0
0
0
129.45%177K
-51.85%-205K
-187.10%-27K
143.97%266K
32.41%143K
Earnings from equity interest net of tax
--0
----
----
----
----
--0
--0
--0
--0
--0
Net income
17.37%-137.06M
25.82%-35.22M
33.54%-26.69M
69.56%-26.87M
-580.87%-48.28M
43.26%-165.87M
22.10%-47.47M
27.70%-40.16M
21.58%-88.28M
115.87%10.04M
Net income continuous Operations
17.37%-137.06M
25.82%-35.22M
33.54%-26.69M
69.56%-26.87M
-580.87%-48.28M
43.26%-165.87M
22.10%-47.47M
27.70%-40.16M
21.58%-88.28M
115.87%10.04M
Minority interest income
0
0
0
0
0
75.44%-28K
0
0
0
34.88%-28K
Net income attributable to the parent company
17.35%-137.06M
25.82%-35.22M
33.54%-26.69M
69.56%-26.87M
-579.53%-48.28M
43.24%-165.84M
22.07%-47.47M
27.68%-40.16M
21.55%-88.28M
115.93%10.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
17.35%-137.06M
25.82%-35.22M
33.54%-26.69M
69.56%-26.87M
-579.53%-48.28M
43.24%-165.84M
22.07%-47.47M
27.68%-40.16M
21.55%-88.28M
115.93%10.07M
Basic earnings per share
18.03%-1.91
25.76%-0.49
33.93%-0.37
70.16%-0.37
-578.57%-0.67
47.87%-2.33
20.48%-0.66
29.11%-0.56
32.97%-1.24
113.08%0.14
Diluted earnings per share
18.03%-1.91
25.76%-0.49
33.93%-0.37
70.16%-0.37
-578.57%-0.67
47.87%-2.33
20.48%-0.66
29.11%-0.56
32.97%-1.24
113.08%0.14
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000067.43M26.87M0040.56M
Operating revenue --0--0--0--0--0--67.43M--26.87M--0--0--40.56M
Cost of revenue
Gross profit
Operating expense -43.11%145.01M-48.76%37.39M-34.41%33.73M-44.65%36.06M-42.09%37.83M0.37%254.88M7.44%72.98M-17.99%51.43M11.65%65.15M0.57%65.33M
Selling and administrative expenses -56.70%37.72M-80.24%7.91M-26.18%10.78M-49.60%8.45M-32.78%10.58M35.37%87.12M144.45%40.01M-8.43%14.61M7.01%16.76M-3.84%15.74M
-General and administrative expense -56.70%37.72M-80.24%7.91M-26.18%10.78M-49.60%8.45M-32.78%10.58M35.37%87.12M144.45%40.01M-8.43%14.61M7.01%16.76M-3.84%15.74M
Research and development costs -36.05%107.3M-10.57%29.49M-37.68%22.95M-42.94%27.61M-45.05%27.25M-11.51%167.77M-36.05%32.97M-21.26%36.82M13.36%48.39M2.06%49.59M
Operating profit 22.64%-145.01M18.91%-37.39M34.41%-33.73M44.65%-36.06M-52.74%-37.83M26.18%-187.46M32.11%-46.11M17.99%-51.43M-11.65%-65.15M61.87%-24.77M
Net non-operating interest income expense
Other net income (expense) -61.44%8.39M267.46%2.62M-37.38%7.04M140.17%9.18M-129.91%-10.45M194.85%21.77M-122.84%-1.56M56.01%11.25M44.40%-22.86M750.52%34.95M
Gain on sale of security -36.52%16.19M20.58%2.62M-37.38%7.04M140.17%9.18M-107.60%-2.66M12.76%25.5M-68.28%2.17M56.01%11.25M-613.66%-22.86M750.52%34.95M
Special income (charges) -108.67%-7.8M--0--0--0---7.8M91.80%-3.74M---3.74M--0--0--0
-Less：Restructuring and merger&acquisition --7.8M--0--0--0--7.8M--0--0--0--0--0
-Less:Impairment of capital assets --0------------------3.74M----------------
Income before tax 17.55%-136.62M27.06%-34.77M33.58%-26.69M69.47%-26.87M-574.11%-48.28M40.16%-165.69M21.94%-47.68M27.61%-40.19M11.52%-88.01M116.74%10.18M
Income tax 149.72%442K315.61%442K000129.45%177K-51.85%-205K-187.10%-27K143.97%266K32.41%143K
Earnings from equity interest net of tax --0------------------0--0--0--0--0
Net income 17.37%-137.06M25.82%-35.22M33.54%-26.69M69.56%-26.87M-580.87%-48.28M43.26%-165.87M22.10%-47.47M27.70%-40.16M21.58%-88.28M115.87%10.04M
Net income continuous Operations 17.37%-137.06M25.82%-35.22M33.54%-26.69M69.56%-26.87M-580.87%-48.28M43.26%-165.87M22.10%-47.47M27.70%-40.16M21.58%-88.28M115.87%10.04M
Minority interest income 0000075.44%-28K00034.88%-28K
Net income attributable to the parent company 17.35%-137.06M25.82%-35.22M33.54%-26.69M69.56%-26.87M-579.53%-48.28M43.24%-165.84M22.07%-47.47M27.68%-40.16M21.55%-88.28M115.93%10.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 17.35%-137.06M25.82%-35.22M33.54%-26.69M69.56%-26.87M-579.53%-48.28M43.24%-165.84M22.07%-47.47M27.68%-40.16M21.55%-88.28M115.93%10.07M
Basic earnings per share 18.03%-1.9125.76%-0.4933.93%-0.3770.16%-0.37-578.57%-0.6747.87%-2.3320.48%-0.6629.11%-0.5632.97%-1.24113.08%0.14
Diluted earnings per share 18.03%-1.9125.76%-0.4933.93%-0.3770.16%-0.37-578.57%-0.6747.87%-2.3320.48%-0.6629.11%-0.5632.97%-1.24113.08%0.14
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -